VES Members and Their Families are Invited to a Fathers’ Day 3D Screening of Walt Disney Pictures’ and Pixar Animation Studios’ TOY STORY 5 Followed by a Q&A

Panelists will include  Visual Effects Supervisor Thomas Jordan, VES Award-winning Director of Photography Matt Aspbury, VES Award-, Annie Award- and Technical Achievement Academy Award-winning Effects Supervisor Stephen Marshall, HPA Award-winning Compositing Lead Peter Demarest and Technical Achievement Academy Award-winning Tools Lead David Eberle, moderated by global VES Board 1st Vice Chair and VES Fellow David Tanaka, VES. (All panelists’ participation based on availability.)

Please tweet your questions after the screening in order to participate in the Q&A panel (which will take place in the San Francisco Bay Area) immediately following the screening. (be sure to include the hashtag, #VESTOYSTORY, in your tweet.)

Please RSVP below (VES members must login to RSVP)
Sunday, June 21, 2026 at 11:00AM (RSVPs close on Friday, June 19 at 12:00PM)
Main Theater on the Walt Disney Studios lot
(Please enter through the Buena Vista Gate between Riverside and Alameda)
500 S. Buena Vista St., Burbank, CA 91451

***VES members please register your name in the “Attendee 1″ fields and guests in the subsequent Attendee fields***

In an effort to prevent the spread of COVID-19, we ask that you or your guests do not attend VES events if you are experiencing any symptoms or if you have been exposed to the virus.

Screenings are overbooked to compensate for no-shows. Seating is limited and will be available on a first come, first served basis. An RSVP does not guarantee seating.

By signing up for this on-site, in-person screening/event sponsored by VES (Visual Effects Society), you willingly accept any potential inherent risks associated with COVID-19. VES cannot be held liable from any consequences that may transpire from said risk. Therefore, signing up for this screening/event infers implied consent of yourself and your party and hereby indemnifies and holds harmless VES, its directors, its employees and any other affiliated persons from any adverse medical or financial impact that may result from our participation.